IndraLab
Statements
reach
"Another study found that the treatment of berberine reduced the activity of NF-κB-related transcription factors p50, p52, p65, c-Rel and RelB in the hippocampus of APP/PS1 mice and increased the activity of IκB protein, thereby inhibiting the activation of the NF-κB pathway and reducing neuroinflammation [96]."